MICROQUIN
MicroQuin is a biotechnology company founded by Dr. Scott Robinson of Imperial College London and Yang Zheng of the University of Chicago. Focused on a novel and broadly impactful target, MicroQuin created smarter therapeutics to address the world’s most challenging diseases, with initial focus on cancer. MicroQuin was a 2018 MassChallenge Finalist (premier global accelerator) and winner of the CASIS/Boeing Prize to fund research on the International Space Station. The company is currently headquartered at the prestigious LabCentral in Kendall Square, Cambridge, MA.
MICROQUIN
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2016-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.microquin.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals is a biotechnology company that focuses on the development of drugs.
Current Employees Featured
Founder
Investors List
MassChallenge
MassChallenge investment in Non Equity Assistance - MicroQuin
Newest Events participated
Official Site Inspections
http://www.microquin.com Semrush global rank: 5.28 M Semrush visits lastest month: 1.56 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "MicroQuin"
MicroQuin | drug development
MicroQuin focuses in-house efforts on Cancer, while progressing Anti-Virals and Neuro with the support of collaborators. OUR PIPELINE > Focusing on transforming cancer treatment for …See details»
MicroQuin - Crunchbase Company Profile & Funding
MicroQuin is a biotechnology company founded by Dr. Scott Robinson of Imperial College London and Yang Zheng of the University of Chicago. Focused on a …See details»
Space-Based 3D Cell Culture Research Paves the Way …
Oct 28, 2024 KENNEDY SPACE CENTER (FL), October 28, 2024 – In October, we think pink, and for a good reason—one out of every eight women will be diagnosed with breast cancer in their lifetime, and each year, 2 million women …See details»
MicroQuin - Overview, News & Similar companies | ZoomInfo.com
Aug 23, 2021 View MicroQuin (www.microquin.com) location in Delaware, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
MicroQuin 2025 Company Profile: Valuation, Funding …
MicroQuin General Information Description. Developer of a biotechnology therapeutics intended to provide a targeted delivery platform for chemotherapy. The company offers a cancer therapy that selectively guides payloads to …See details»
MicroQuin - VentureRadar
MicroQuin has developed first-in-class therapies that manipulate a transmembrane target critical to tumorigenesis and cancer cell survival. The unique interaction of our therapy with this novel …See details»
MicroQuin - HQ - The Org
MicroQuin's headquarters in Cambridge, MA, United States. Scott Robinson, PhD, CQF. President and CSOSee details»
MicroQuin - Products, Competitors, Financials, Employees, …
MicroQuin found that targeting a specific protein called TMBIM6 that regulates the intracellular environment and defines cell structure can kill cancer cells. MicroQuin researchers developed …See details»
MicroQuin - Funding, Financials, Valuation & Investors - Crunchbase
Sep 19, 2018 MicroQuin is a pre-clinical biotechnology company with first-in-class, lead compounds that use two technologies to kill breast cancers. New. Resources. ... How much …See details»
MicroQuin | SF, CA, USA Startup - Gust
Microquin is focusing efforts on it’s ‘homing device’ for chemotherapeutics. Our Cell Penetrating Peptide (CPP) can selectively target cancerous cells, including breast, lung, prostate, ovarian …See details»
MicroQuin - Company Profile - Tracxn
Oct 29, 2024 MicroQuin - Developer of therapies for treating multiple diseases. Raised funding over 1 round from 1 investor. Founded by Scott Robinson in the year 2016. MicroQuin has …See details»
MicroQuin: hunting down breast cancer - Nature
MicroQuin’s co-founders have self-funded their research while actively seeking grants and investments. They are seeking to partner the CPP technology with major players in the …See details»
Vickers Venture Website
He is the founder of MicroQuin, a biotechnology company developing novel treatments within oncology, anti-infectives and neurodegenerative diseases. Scott is experienced in defining …See details»
Space-Based 3D Cell Culture Research Paves The Way For New …
Oct 28, 2024 Through MicroQuin's ISS National Lab-sponsored research, the team identified microgravity-induced changes in cancer cell signaling that revealed something critical to …See details»
MicroQuin - Contacts, Employees, Board Members, Advisors
Organization. MicroQuin . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. MicroQuin has 1 …See details»
Breakthrough Cancer Treatment Emerges from Space Station …
In a groundbreaking development, biotechnology startup MicroQuin has made a significant breakthrough in cancer treatment using research conducted on the International Space Station …See details»
MicroQuin to Launch Cancer Research to the ISS - ISS National Lab
February 17, 2022. KENNEDY SPACE CENTER (FL), February 17, 2022 – An investigation from biotechnology startup MicroQuin launching to the International Space Station (ISS …See details»
MicroQuin - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. MicroQuin . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 28. About. MicroQuin is …See details»
MicroQuin’s Space-Based Research Uncovers New Pathways in …
Oct 22, 2024 MicroQuin carried out two major investigations to investigate the behaviour of cancer cells in space. Crystallising the TMBIM6 protein TMBIM6 (Transmembrane BAX …See details»
MicroQuin's Space Research Paves Way for Potential Cancer …
Nov 4, 2024 Biotechnology startup MicroQuin leveraged the International Space Station (ISS) National Laboratory to grow 3D breast and prostate cancer cell cultures to learn more about …See details»